Colgate-Palmolive (CL) Stock Forecast & Price Target

$92.80 +2.85 (+3.17%)

Closing price 10/14/2026 03:59 PM Eastern

Extended Trading

$93.48 +0.69 (+0.74%)

As of 07:36 AM Eastern

Compare

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 20 Analyst Ratings

Sell
0

Hold
7

Buy
13

Based on 20 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 7 have given a hold rating, and 13 have given a buy rating for CL.

Consensus Price Target

$98.11
5.72% Upside

According to the 20 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $98.11. The highest price target for CL is $110.00, while the lowest price target for CL is $87.00. The average price target represents a forecasted upside of 5.72% from the current price of $92.80.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CL Analyst Ratings Over Time

Type	Current Forecast 10/15/25 to 10/15/26	1 Month Ago 9/15/25 to 9/15/26	3 Months Ago 7/17/25 to 7/17/26	1 Year Ago 10/15/24 to 10/15/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	8 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$98.11	$98.56	$97.06	$92.21
Forecasted Upside	5.72% Upside	13.29% Upside	4.54% Upside	18.73% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	Broader Market
Consensus Rating Score	2.65	2.22	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	5.72% Upside	175.38% Upside	19.53% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/9/2026	Bank of America 4 of 5 stars	Bryan Spillane 1 of 5 stars	Lower Target	Buy	$102.00 ➝ $100.00	+13.39%
10/8/2026	Evercore 3 of 5 stars		Boost Target	Outperform	$100.00 ➝ $101.00	+14.52%
10/5/2026	Wells Fargo & Company 3 of 5 stars	Chris Carey 3 of 5 stars	Lower Target	Equal Weight	$95.00 ➝ $90.00	+5.00%
10/2/2026	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings		Downgrade	Buy (B-) ➝ Hold (C+)
9/28/2026	BNP Paribas Exane Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target	Outperform	$101.00 ➝ $97.00	+9.98%
9/21/2026	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Lavery Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Overweight	$98.00 ➝ $95.00	+8.57%
9/8/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Nik Modi Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Outperform	$104.00	+17.54%
8/13/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access to unlock brokerage rankings	Cristian Rios Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Market Perform
8/3/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access to unlock brokerage rankings	Steve Powers Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$99.00 ➝ $101.00	+10.42%
8/3/2026	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Dara Mohsenian Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Overweight	$100.00 ➝ $104.00	+12.06%
Get the Latest News and Ratings for CL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.
8/3/2026	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Peter Grom Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$106.00 ➝ $109.00	+17.45%
8/3/2026	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Robert Moskow Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Hold	$85.00 ➝ $90.00	-3.03%
8/3/2026	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Hold	$88.00 ➝ $89.00	-2.51%
8/3/2026	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings		Boost Target	Outperform	$100.00 ➝ $102.00	+15.65%
8/3/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Andrea Teixeira Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Overweight	$104.00 ➝ $103.00	+12.67%
7/21/2026	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Lauren Lieberman Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Equal Weight	$80.00 ➝ $87.00	-5.36%
7/14/2026	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Filippo Falorni Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$105.00 ➝ $110.00	+18.09%
5/1/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Buy	$100.00 ➝ $98.00	+12.45%
4/21/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access to unlock brokerage rankings	Edward Lewis Subscribe to MarketBeat All Access to unlock analyst rankings	Set Target	Neutral ➝ Buy	$93.00 ➝ $100.00	+19.78%
12/11/2025	Argus Subscribe to MarketBeat All Access to unlock brokerage rankings	Taylor Conrad Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy ➝ Hold
10/30/2025	HSBC Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target		$92.00 ➝ $88.00	-0.22%
2/3/2025	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Mark Astrachan Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Hold	$95.00 ➝ $93.00	+7.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:36 AM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 8, 2026. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

Colgate-Palmolive shares are currently trading at $88.07, which is significantly below the consensus price target of $98.94 set by analysts, suggesting potential upside of over 12% for investors who believe the current valuation is too low.
The company recently reported earnings per share of $0.99 for the quarter ended July 31, 2026, which beat the consensus estimate of $0.947, demonstrating strong profitability and operational efficiency that supports the stock's fundamental value.
With a dividend yield of 2.43% and a recent quarterly dividend of $0.53 per share, Colgate-Palmolive offers a reliable income stream that is attractive to income-focused investors seeking stability in a volatile market.
The stock has a low beta of 0.33, indicating that it is less volatile than the overall market, which makes it a defensive investment that can help reduce portfolio risk during economic downturns.
Recent institutional activity shows strong buying interest, with funds like Sapient Capital LLC increasing their position by 240% and Horrell Capital Management Inc. adding 19,288 shares in the third quarter, signaling confidence in the company's future performance.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

The company's payout ratio is 84.13%, which is quite high and may limit its ability to reinvest in growth initiatives or absorb financial shocks, potentially constraining long-term earnings growth.
Recent insider selling activity is notable, with CEO Noel Wallace selling 161,021 shares and COO Panagiotis Tsourapas selling 10,000 shares in August 2026, which could signal a lack of confidence in the stock's near-term prospects.
Several analysts have recently lowered their price targets, such as Wells Fargo cutting its target from $95.00 to $90.00 and Piper Sandler reducing its target from $98.00 to $95.00, reflecting a more cautious outlook on the company's valuation and growth potential.
The stock is trading below its 50-day moving average of $89.16 and its 200-day moving average of $88.77, indicating that the short-term and medium-term momentum is negative and the stock may be in a downtrend.
Short interest has increased slightly, with shares shorted rising to 18,399,416 in September 2026 from 17,171,315 in August, suggesting that some investors are betting against the stock's price appreciation in the near term.

CL Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $98.11, with a high forecast of $110.00 and a low forecast of $87.00.

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 7 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 5.72% based on their 12-month stock forecasts.

Over the previous 90 days, Colgate-Palmolive's stock had 1 upgrade and 1 downgrade by analysts.

Colgate-Palmolive has been rated by research analysts at Bank of America, Barclays, BNP Paribas Exane, Deutsche Bank Aktiengesellschaft, Evercore, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Raymond James Financial, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

MarketBeat monitors more than a dozen sources for Colgate-Palmolive analyst ratings, with the most recent rating issued on 10/9/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CL Analyst Ratings Over Time

CL Analyst Recommendations By Month

CL Price Targets by Month

Colgate-Palmolive Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

Colgate-Palmolive
Bull Case

Colgate-Palmolive
Bear Case

CL Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CL Analyst Ratings Over Time

CL Analyst Recommendations By Month

CL Price Targets by Month

Colgate-Palmolive Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

Colgate-Palmolive Bull Case

Colgate-Palmolive Bear Case

CL Forecast - Frequently Asked Questions

What is Colgate-Palmolive's forecast for 2026?

Should I buy or sell Colgate-Palmolive stock right now?

Does Colgate-Palmolive's stock price have much upside?

Has Colgate-Palmolive been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Colgate-Palmolive?

Do Wall Street analysts like Colgate-Palmolive more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Colgate-Palmolive
Bull Case

Colgate-Palmolive
Bear Case